Concepedia

Sriram Tyagarajan

ST

20

Publications

1.4K

Citations

16

H-Index

1994

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

Synaptic Research (United States)

Sriram Tyagarajan is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

ORCID

Top concepts

Publications per year

1994–2023

20

Publications

20

An orally available non-nucleotide STING agonist with antitumor activity

Bo‐Sheng Pan, Samanthi A. Perera, Jennifer Piesvaux et al. · Science · 2020 · 609 citations

, , +19

Exploration of the internal cavity of histone deacetylase (HDAC) with selective HDAC1/HDAC2 inhibitors (SHI-1:2)

Joey L. Methot, Prasun K. Chakravarty, Mélissa Chénard et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 185 citations · Full text

, , +10

Design, Synthesis and Evaluation of Substituted Triarylnipecotic Acid Derivatives as GABA Uptake Inhibitors: Identification of a Ligand with Moderate Affinity and Selectivity for the Cloned Human GABA Transporter GAT-3

T. G. Murali Dhar, Laurence A. Borden, Sriram Tyagarajan et al. · Journal of Medicinal Chemistry · 1994 · 124 citations · Full text

, , +14

Design and Synthesis of Novel α<sub>1</sub><sub>a</sub> Adrenoceptor-Selective Antagonists. 1. Structure−Activity Relationship in Dihydropyrimidinones

Dhanapalan Nagarathnam, Shou Wu Miao, Bharat Lagu et al. · Journal of Medicinal Chemistry · 1999 · 112 citations · Full text

, , +16

Bismuth Acetate as a Catalyst for the Sequential Protodeboronation of Di- and Triborylated Indoles

Fangyi Shen, Sriram Tyagarajan, Damith Perera et al. · Organic Letters · 2016 · 42 citations

, , +16

Rows per page

1–5 of 20